Literature DB >> 23831161

Management strategies and outcome for prosthetic valve endocarditis.

Fabio Chirillo1, Piergiorgio Scotton, Francesco Rocco, Roberto Rigoli, Alessandra Pedrocco, Paola Martire, Alessandro Daniotti, Giuseppe Minniti, Elvio Polesel, Zoran Olivari.   

Abstract

The aim of this study was to assess the impact of an operative protocol with a multidisciplinary approach on the outcome of patients with prosthetic valve endocarditis (PVE). A formal policy for the care of PVE was introduced at our hospital in 2003 in which patients were referred to and managed by a preexisting team involving a cardiologist, a specialist in infectious diseases, and a cardiac surgeon. All patients underwent transesophageal echocardiography as soon as clinical suspicion of PVE arose. If high-risk conditions such as heart failure, ring abscess, conditions associated with impending malfunctioning of the prosthesis, or vegetations at high risk for systemic embolization were found during the initial multidisciplinary evaluation (performed within 12 hours of admission), patients were operated on within 48 hours. Stable patients were evaluated weekly by the multidisciplinary team, and on-treatment surgery was performed whenever high-risk conditions developed or when there was persistent fever/bacteremia after 1 week of adequate antibiotic therapy. Comparing the period 2003 through 2009 with 1996 through 2002 (when a multidisciplinary policy was not followed), patients with PVE were more numerous (61 vs 38), older (mean age 68.3 vs 63.1, p = 0.01), and had more co-morbidities (mean Charlson index 3.15 vs 2.42, p = 0.03). The most frequent causative organisms were Staphylococci in both periods. In the second period, fewer patients had delayed diagnosis (39% vs 71%, p = 0.03), heart failure (20% vs 45%, p = 0.01), abscess (20% vs 39%, p = 0.04), culture-negative infective endocarditis (11% vs 29%, p = 0.03), and worsened renal function (21% vs 42%, p = 0.04). A significant reduction in in-hospital mortality (53% to 23%, p = 0.04) and 3-year mortality (60% to 28%, p = 0.001) was observed, driven by the increased number of patients successfully treated with medical therapy alone (44% vs 16%, p = 0.04). In conclusion, formalized, collaborative management led to significant improvement in PVE-related mortality.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23831161     DOI: 10.1016/j.amjcard.2013.05.059

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  [Infective endocarditis : New ESC guidelines 2015].

Authors:  B Plicht; A Lind; R Erbel
Journal:  Internist (Berl)       Date:  2016-07       Impact factor: 0.743

Review 2.  Infective endocarditis: therapeutic options and indications for surgery.

Authors:  Aneil Malhotra; Jenny Rayner; Timothy M Williams; Bernard Prendergast
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

Review 3.  Valve-related complications after mechanical heart valve implantation.

Authors:  Yoshio Misawa
Journal:  Surg Today       Date:  2014-12-18       Impact factor: 2.549

4.  Management of prosthetic joint infections in France: a national audit to identify key situations requiring innovation and homogenization.

Authors:  Marion Le Maréchal; Zoé Cavalli; Cécile Batailler; Jean-François Gonzalez; André Ferreira; Sébastien Lustig; Tristan Ferry; Johan Courjon
Journal:  BMC Infect Dis       Date:  2021-05-01       Impact factor: 3.090

5.  Surgical treatment of valve endocarditis in high-risk patients and predictors of long-term outcomes.

Authors:  Giuseppe Nasso; Giuseppe Santarpino; Marco Moscarelli; Ignazio Condello; Angelo Maria Dell'Aquila; Armin Darius Peivandi; Mario Gaudino; Flavio Fiore; Pasquale Mastroroberto; Nicola Di Bari; Giuseppe Speziale
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

6.  Validated Risk Score for Predicting 6-Month Mortality in Infective Endocarditis.

Authors:  Lawrence P Park; Vivian H Chu; Gail Peterson; Athanasios Skoutelis; Tatjana Lejko-Zupa; Emilio Bouza; Pierre Tattevin; Gilbert Habib; Ren Tan; Javier Gonzalez; Javier Altclas; Jameela Edathodu; Claudio Querido Fortes; Rinaldo Focaccia Siciliano; Orathai Pachirat; Souha Kanj; Andrew Wang
Journal:  J Am Heart Assoc       Date:  2016-04-18       Impact factor: 5.501

Review 7.  Three-Dimensional Transesophageal Echocardiography in the Diagnosis and Treatment of Mitral Prosthetic Valve Endocarditis-A Narrative Review.

Authors:  Vedran Carević; Zorica Mladenović; Ružica Perković-Avelini; Tina Bečić; Mislav Radić; Damir Fabijanić
Journal:  Medicina (Kaunas)       Date:  2021-12-23       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.